跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HALOXIN TABLET 200 MG - HSA Drug Approval Details
Approvals
/
HSA
/
HALOXIN TABLET 200 MG
Approved
THERAPEUTIC
HALOXIN TABLET 200 MG
HANLIM PHARMACEUTICAL CO LTD (KOREA, REPUBLIC OF)
🇸🇬 Health Sciences Authority
Approval Date
Jun 28, 2005
Approval ID
30bcf39896d725c6
Company
HANLIM PHARMACEUTICAL CO LTD (KOREA, REPUBLIC OF)
Type
Therapeutic
Approval Details
Approval Id
30bcf39896d725c6
Drug Name
HALOXIN TABLET 200 MG
Product Name
HALOXIN TABLET 200 MG
Approval Number
SIN12669P
Approval Date
2005-06-28
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, SUGAR COATED
Route Of Administration
ORAL
Atc Code
P01BA02
Atc Item Name
hydroxychloroquine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
HYDROXYCHLOROQUINE SULFATE
200 mg
HYDROXYCHLOROQUINE SULFATE
200 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 28, 2005
Approval ID
30bcf39896d725c6
Type
Therapeutic
Back to HSA Approvals